Gilead Sciences
GILD stock analysis · Health Care · Biotechnology
As of · fund-implied per-share value
Fund holding value ÷ shares held. Not a live quote; not adjusted for later stock splits.
View SEC fund filing ↗Price × SEC outstanding shares. Shares measured 2026-06-30. Approximate; share and price dates can differ.
View share-count filing ↗Momentum data and stock-split review
The current issuer FAQ lists all five completed stock splits, ending in December 2012, and identifies the current Nasdaq GILD listing. The reviewed same-ISIN endpoint pair starts after those splits. Split multiplier 1 is an issuer-history-based inference limited to this snapshot. Cash dividends are excluded. Fund values divided by held shares are indicative price-return proxies, not exchange closes or total returns.
Fund valuation at 2025-06-30 ↗ · Fund valuation at 2026-05-31 ↗
DCF value
Equity cash-flow scenario · SEC outstanding shares at 2026-06-30 · -8.4% versus input cap
How this is calculated ↗Reverse DCF
Annual basis · read assumptions below
How this is calculated ↗Relative valuation
6 industry peers · median 25.0×
How this is calculated ↗Historical multiples
7 annual observations · snapshot P/E 18.4× · -9.3% versus history
How this is calculated ↗Free cash flow yield
Annual basis · read assumptions below
How this is calculated ↗ROIC / quality
Normalized tax · financing-capital proxy · parent-equity fallback (scope limitation) · short-term borrowing coverage incomplete
How this is calculated ↗Value composite
Annual basis · read assumptions below
How this is calculated ↗12–1 price momentum
2025-06-30 → 2026-05-31 · Reviewed split basis · fund snapshot
How this is calculated ↗Asset growth
Annual basis · read assumptions below
How this is calculated ↗Net payout yield
Annual basis · read assumptions below
How this is calculated ↗Accrual quality
Annual basis · read assumptions below
How this is calculated ↗Fundamental momentum
Annual basis · read assumptions below
How this is calculated ↗Follow the cash
ANNUAL · USDOperating cash flow and reinvestment over time
Annual USD. Negative bars use a compressed lower scale. Hover or inspect the financial history table for exact values.
Make the assumptions yours
How sensitive is the valuation?
| Return / Growth | 3.0% | 5.0% | 7.0% |
|---|---|---|---|
| 8.0% | $145.16 | $158.38 | $172.60 |
| 10.0% | $106.37 | $115.73 | $125.78 |
| 12.0% | $83.92 | $91.06 | $98.72 |
Annual financial history
Open SEC filings ↗| Fiscal year-end | Revenue | Net income | Operating cash flow | Capital expenditure | Assets |
|---|---|---|---|---|---|
| 2025-12-31 | 29.4B | 8.5B | 10B | 563M | 59B |
| 2024-12-31 | 28.8B | 480M | 10.8B | 523M | 59B |
| 2023-12-31 | 27.1B | 5.6B | 8B | 585M | 62.1B |
| 2022-12-31 | 27.3B | 4.6B | 9.1B | 728M | 63.2B |
| 2021-12-31 | 27.3B | 6.2B | 11.4B | 579M | 68B |
| 2020-12-31 | 24.7B | 89M | 8.2B | 650M | 68.4B |
| 2019-12-31 | 22.4B | 5.4B | 9.1B | 825M | 61.6B |
| 2018-12-31 | 22.1B | 5.5B | 8.4B | 924M | 63.7B |
USD, abbreviated. Restated annual history; not a point-in-time backtest. Missing values appear as dashes.
Trace the inputs
MODEL ANNUAL PERIOD| Input | Value | SEC tag / source | Filed |
|---|---|---|---|
| revenue | 29.4B | RevenueFromContractWithCustomerExcludingAssessedTax | 2026-02-24 |
| netIncome | 8.5B | ProfitLoss Explicit consolidated amount, including the portion attributable to noncontrolling interests. | 2026-02-24 |
| Parent/common earnings proxy | 8.5B | NetIncomeLoss | 2026-02-24 |
| cfo | 10B | NetCashProvidedByUsedInOperatingActivities | 2026-02-24 |
| capex | 563M | PaymentsToAcquirePropertyPlantAndEquipment | 2026-02-24 |
| operatingIncome | 10B | OperatingIncomeLoss | 2026-02-24 |
| assets | 59B | Assets | 2026-02-24 |
| equity | 22.7B | StockholdersEquity Parent-attributable fallback: a verified consolidated total is unavailable in the supported tags. Noncontrolling interests have not been assumed to be zero; this may differ in scope from consolidated cash flow or operating income. | 2026-02-24 |
| Parent book equity proxy | 22.7B | StockholdersEquity | 2026-02-24 |
| debt | 24.9B | LongTermDebt | 2026-02-24 |
| shortDebt | — | Not reported under a supported tag | — |
| cash | 7.6B | CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents | 2026-02-24 |
| shares | 1.3B | WeightedAverageNumberOfDilutedSharesOutstanding | 2026-02-24 |
| dividends | 4B | PaymentsOfDividends | 2026-02-24 |
| buybacks | 1.9B | PaymentsForRepurchaseOfCommonStock | 2026-02-24 |
| issuance | 408M | ProceedsFromIssuanceOfCommonStock | 2026-02-24 |